Prolonged low-dose intravenous thrombolysis in a stroke patient with distal basilar thrombus

被引:11
作者
Veltkamp, R
Jacobi, C
Kress, B
Hacke, W
机构
[1] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany
关键词
ischemia; magnetic resonance imaging; reperfusion; thrombolysis;
D O I
10.1161/01.STR.0000195171.29940.79
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Patients with high-grade basilar artery stenosis secondary to thromboembolism are at high risk of developing subsequent vessel occlusion. Optimal medical management of this condition is unclear. Summary of Case - We present a patient with a small subacute brain stem infarction and filiform distal basilar residual lumen attributable to arterioarterial or cardiogenic embolism. Beginning 3 days after symptom onset, low-dose intravenous thrombolysis with 0.125 mg/kg recombinant tissue plasminogen activator was continuously infused for 48 hours. Follow-up magnetic resonance angiography revealed complete resolution of the embolus. No further cerebral ischemic episodes occurred during 3-month follow-up, and the basilar artery remained patent. Conclusion - Our observation suggests a potential for prolonged low-dose intravenous thrombolysis in basilar artery embolism, but further data are needed to judge the effectiveness and risk of this intervention.
引用
收藏
页码:E9 / E11
页数:3
相关论文
共 9 条
[1]   Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator [J].
Fassbender, K ;
Dempfle, CE ;
Mielke, O ;
Schwartz, A ;
Daffertshofer, M ;
Eschenfelder, C ;
Dollman, M ;
Hennerici, M .
STROKE, 1999, 30 (10) :2101-2104
[2]  
Herron Sandra B, 2004, J Invasive Cardiol, V16, P35
[3]   Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD) [J].
Kulkarni, S ;
Rodriguez, M ;
Lafuente, A ;
Mateos, P ;
Mehta, J ;
Singhal, S ;
Saso, R ;
Dait, D ;
Treleaven, JG ;
Powles, RL .
BONE MARROW TRANSPLANTATION, 1999, 23 (08) :803-807
[4]  
Madhavan P, 2002, Vasc Endovascular Surg, V36, P351, DOI 10.1177/153857440203600504
[5]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587
[6]   An update on thrombolytic therapy for acute stroke [J].
Schellinger, PD ;
Kaste, M ;
Hacke, W .
CURRENT OPINION IN NEUROLOGY, 2004, 17 (01) :69-77
[7]   Imaging-based decision making in thrombolytic therapy for ischemic stroke - Present status [J].
Schellinger, PD ;
Fiebach, JB ;
Hacke, W .
STROKE, 2003, 34 (02) :575-582
[8]   Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during Alteplase double-bolus regimen in acute myocardial infarction [J].
Stangl, K ;
Laule, M ;
Tenckhoff, B ;
Stangl, V ;
Gliech, V ;
Dübel, P ;
Grohmann, A ;
Melzer, C ;
Langel, J ;
Wernecke, KD ;
Baumann, G ;
Ziemer, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (07) :841-847
[9]   Low-dose tissue plasminogen activator thrombolysis in children [J].
Wang, M ;
Hays, T ;
Balasa, V ;
Bagatell, R ;
Gruppo, R ;
Grabowski, EF ;
Valentino, LA ;
Tsao-Wu, G ;
Manco-Johnson, MJ .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (05) :379-386